Changing Trends in Advanced Epithelial Ovarian Cancer: A Review

Authors

  • Vijaykumar D.K. M.S. M.Ch (Surgical Oncology),Professor & Amp; Head, Dept. of Surgical Oncology, Amrita Institute of Medical Sciences and Research Centre, Ponekkara P.O., Cochin - 682 041
  • Anupama Rajanbabu Department of Gynecologic Oncology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwavidyapeetham, Cochin-682041, Kerala, India

Abstract

Despite the advances in surgery and chemotherapy, the outcome of patients affected with advanced epithelial ovarian cancer continues to be poor. Now researchers are looking at ovarian cancer through newer perspectives so as to find better treatment modalities that can improve overall survival (OS).  In this chapter, we have briefly reviewed the newer areas of research in epithelial ovarian cancer. We look at how better understanding of the molecular biology, changes in mode of chemotherapy administration and newer targeted agents have improved the outlook for the future.

 

 

Keywords: Epithelial ovarian cancer, Cancer stem cell, Optimal debulking, Chemotherapy in ovarian cancer

Author Biography

  • Vijaykumar D.K., M.S. M.Ch (Surgical Oncology),Professor & Amp; Head, Dept. of Surgical Oncology, Amrita Institute of Medical Sciences and Research Centre, Ponekkara P.O., Cochin - 682 041
    Dr. D.K. Vijaykumar M.S. M.Ch (Surgical Oncology)
    Professor & Head, Dept. of Surgical Oncology
    Amrita Institute of Medical Sciences and Research Centre

Downloads

Published

2014-08-27

Issue

Vol. 3 No. 2 (2014)

Section

Review Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.